Back

Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart failure with mid-range and preserved ejection fraction Diastolic dysfunction ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Mauro Gori

Papa Giovanni XXIII Hospital, Bergamo (Italy)

4 More presentations in this session

Presentation thumbnail
State of the Art: HFmrEF - The new middle child
Professor R. De Boer (Rotterdam, NL)
Presentation thumbnail
Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction
Doctor G. Savarese (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Should we abandon EF to stratify heart failure treatment?
Professor S. Solomon (Boston, US)
Slides Video

Access the full session

Session thumbnail
Heart failure with mid-range and preserved ejection fraction

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources